Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Marek Z, Wojtukiewicz"'
Autor:
Barbara Boczkowska-Radziwon, Piotr Józef Olbromski, Anna Rogowska, Magdalena Bujno, Marta Myśliwiec, Agnieszka Żebrowska, Dariusz Średziński, Barbara Polityńska, Marek Z. Wojtukiewicz, Piotr Radziwon
Publikováno v:
Biomolecules, Vol 12, Iss 2, p 164 (2022)
Autohemotherapy with ozonated blood is used in the treatment of a broad spectrum of clinical disorders. Ozone demonstrates strong oxidizing properties and causes damage to cell membranes. The impact of whole-blood ozonation on the release of micropar
Externí odkaz:
https://doaj.org/article/1f07fb93c2ad4a78881e1b6c688b1185
Autor:
Kamil Grubczak, Anna Kretowska-Grunwald, Dawid Groth, Izabela Poplawska, Andrzej Eljaszewicz, Lukasz Bolkun, Aleksandra Starosz, Jordan M. Holl, Marta Mysliwiec, Joanna Kruszewska, Marek Z. Wojtukiewicz, Marcin Moniuszko
Publikováno v:
Cells, Vol 10, Iss 8, p 2044 (2021)
Drugs targeting immune checkpoint molecules have been found effective in melanoma, lung cancer, and other malignancies treatment. Recent studies on breast cancer demonstrated the significance of inhibitory anti-CTLA-4 and anti-PD-1 in the regulation
Externí odkaz:
https://doaj.org/article/1f253e6f83764c349eca0f218fdb1a7f
Publikováno v:
Cancer and Metastasis Reviews. 41:465-469
Autor:
Marek Z. Wojtukiewicz, Marta Mysliwiec, Elwira Matuszewska, Stanislaw Sulkowski, Lech Zimnoch, Barbara Politynska, Anna M. Wojtukiewicz, Stephanie C. Tucker, Kenneth V. Honn
Publikováno v:
Biomolecules, Vol 11, Iss 5, p 663 (2021)
Neoplastic processes are integrally related to disturbances in the mechanisms regulating hemostatic processes. Brain tumors, including gliomas, are neoplasms associated with a significantly increased risk of thromboembolic complications, affecting 20
Externí odkaz:
https://doaj.org/article/7712933e180d48bfb85f3c7c64b01693
Publikováno v:
Contemporary Oncology, Vol 20, Iss 2, Pp 102-108 (2016)
Operable pancreatic cancer is characterized by a high risk of recurrence. Efforts are made to incorporate new therapies. Throughout the world there is a lack of uniform recommendations concerning the adjuvant treatment of pancreatic cancer patients,
Externí odkaz:
https://doaj.org/article/7a2a8654f0994cc3813e7469fbf8d6a1
Autor:
Karolina Piekarska, Rafał Zyśk, Maciej Krzakowski, Jan Walewski, Barbara Polityńska, Marek Z. Wojtukiewicz
Publikováno v:
Oncology in Clinical Practice. 18:40-60
Publikováno v:
OncoReview. 11:68-72
Pancreatic cancer is a disease with high mortality. It is predicted to become the second leading cause of cancer death in some regions of the world. Frequent diagnosis at an advanced stage contributes to 5-year survival at a highly unsatisfactory lev
Autor:
Anna M. Wojtukiewicz, Marek Z. Wojtukiewicz, Marcin Moniuszko, Maria Gorska, Piotr Radziwon, Barbara Politynska, Stephanie C. Tucker, Kamil Karpowicz, Magdalena M. Rek, Kenneth V. Honn
Publikováno v:
Cancer Metastasis Reviews
The treatment of cancer patients with immune checkpoint inhibitors (ICI) (anti-CTLA-4, anti-PD-1, anti-PD-L1, combined therapy anti-PD-1/PD-L1 with anti-CTLA-4) has without doubt been a significant breakthrough in the field of oncology in recent year
Autor:
Barbara Polityńska, Olga Pokorska, Anna M. Wojtukiewicz, Magdalena Sawicka, Marta Myśliwiec, Kenneth V. Honn, Stephanie C. Tucker, Marek Z. Wojtukiewicz
Publikováno v:
Pharmacologytherapeutics. 240
Patients with cancer are at greater risk of developing depression in comparison to the general population and this is associated with serious adverse effects, such as poorer quality of life, worse prognosis and higher mortality. Although the relation
Autor:
Piotr Radziwon, Dariusz M. Kowalski, Maciej Krzakowski, Jerzy Gryglewicz, Marek Z. Wojtukiewicz, Ewa Kalinka, Renata Zaucha, Piotr J. Wysocki
Publikováno v:
Oncology in Clinical Practice. 16:261-269
Anemia is a common feature in about 40% of patients at the moment of cancer diagnosis and in more than half of patients on anticancer therapy. Therapeutic alternatives in cancer patients with anemia include substitution of lacking agents, red blood c